Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients.
Casetti R, Sacchi A, Mazzotta V, Cristofanelli F, Grassi G, Gili S, Cimini E, Notari S, Bordoni V, Mastrorosa I, Giancola ML, Vergori A, Tempestilli M, Vita S, Mariotti D, Rosati S, Lalle E, Meschi S, Colavita F, Garbuglia AR, Girardi E, Nicastri E, Antinori A, Agrati C.
Casetti R, et al. Among authors: giancola ml.
Int Immunopharmacol. 2025 Feb 20;148:113934. doi: 10.1016/j.intimp.2024.113934. Epub 2025 Jan 19.
Int Immunopharmacol. 2025.
PMID: 39832460